Pérez López, G <br/><br/>
[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].  [electronic resource] 

 -  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia  2010 
 - 618-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0211-6995 
<br/><br/><label>Standard No.: </label>10.3265/Nefrologia.pre2010.Sep.10494  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorption<br/>Animals<br/>Benzhydryl Compounds<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dogs<br/>Double-Blind Method<br/>Gluconeogenesis--drug effects<br/>Glucose--metabolism<br/>Glucosides--adverse effects<br/>Glycosuria, Renal--drug therapy<br/>Homeostasis<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Kidney--metabolism<br/>Kidney Tubules, Proximal--metabolism<br/>Mice<br/>Phlorhizin--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Sodium-Glucose Transporter 1--physiology<br/>Sodium-Glucose Transporter 2--genetics<br/>Sodium-Glucose Transporter 2 Inhibitors